PMVP
Pmv Pharmaceuticals Inc
NASDAQ: PMVP · HEALTHCARE · BIOTECHNOLOGY
$1.39
-2.11% today
Updated 2026-04-29
Market cap
$74.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
Pmv Pharmaceuticals Inc (PMVP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — |
| Cost of revenue | $338000.00 | $388000.00 | $318000.00 | $1.28M | $650000.00 | $1.26M | $1.14M | $133000.00 |
| Gross profit | $-338000.00 | $-388000.00 | $-318000.00 | $-1.28M | $-650000.00 | $-1.26M | $-1.14M | $-133000.00 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $13.85M | $20.76M | $23.93M | $36.49M | $51.99M | $54.63M | $57.38M | $69.88M |
| SG&A | $5.04M | $5.88M | $11.01M | $21.80M | $25.05M | $24.25M | $26.92M | $16.33M |
| Operating income | $-18.89M | $-26.64M | $-34.94M | $-58.29M | $-77.04M | $-80.13M | $-85.45M | $-86.21M |
| Operating margin | — | — | — | — | — | — | — | — |
| EBITDA | $-18.55M | $-24.96M | $-34.62M | $-57.99M | $-76.72M | $-67.70M | $-73.67M | $-86.21M |
| EBITDA margin | — | — | — | — | — | — | — | — |
| EBIT | $-18.89M | $-25.34M | $-34.94M | $-58.29M | $-77.04M | $-68.96M | $-74.81M | $-86.34M |
| Interest expense | $0.00 | $1.29M | $826000.00 | $777000.00 | $4.03M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.54M | $-25.35M | $-34.44M | $-57.85M | $-73.32M | $-68.96M | $-58.71M | $-77.74M |
| Net income growth (YoY) | — | -44.6% | -35.8% | -68.0% | -26.7% | +5.9% | +14.9% | -32.4% |
| Profit margin | — | — | — | — | — | — | — | — |